Application 077702

Type
ANDA
Sponsor
AUROBINDO

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001NEVIRAPINENEVIRAPINESUSPENSION;ORAL50MG/5MLNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
65862-057NevirapineNevirapineAurobindo Pharma LimitedANDACurrent
65862-057NevirapineNevirapineAurobindo Pharma LimitedANDACurrent
65862-057NevirapineNevirapineAurobindo Pharma LimitedANDACurrent
65862-057NevirapineNevirapineAurobindo Pharma LimitedANDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
31280ORIG2006-01-06